Arbutus Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.17	18.01	36.33	26.29	30.78	109.28
Short-Term Investments	73.45	73.46	86.29	99.72	116.14	46.04
Cash & Short-Term Investments	92.63	91.47	122.62	126	146.91	155.32
Cash Growth	-5.57%	-25.41%	-2.68%	-14.23%	-5.41%	26.00%
Accounts Receivable	0.37	1.45	2.41	1.78	1.35	0.9
Other Receivables	179.37	-	-	-	-	-
Total Trade Receivables	179.74	1.45	2.41	1.78	1.35	0.9
Other Current Assets	1.52	1.54	2.28	4.25	2.87	4.45
Total Current Assets	273.88	94.46	127.32	132.03	151.14	160.66
Net Property, Plant & Equipment	-	-	1.05	6.09	6.81	8.08
Long-Term Investments	-	-	-	6.28	37.36	35.69
Other Long-Term Assets	0.13	0.13	0.03	-	0.1	0.06
Total Assets	274.03	94.62	131.71	144.4	195.42	204.49
Accounts Payable	2.85	5.46	7.56	10.27	16.03	10.84
Current Portion of Leases	0.51	0.55	0.48	0.43	0.37	0.38
Unearned Revenue	-	-	7.57	11.79	16.46	-
Total Current Liabilities	3.36	6.01	15.62	22.49	32.86	11.22
Long-Term Debt	3.11	3.44	4.83	6.95	10.37	16.3
Long-Term Leases	-	0.2	0.81	1.34	1.82	2.23
Other Long-Term Liabilities	8.82	8.4	13.09	7.6	13.53	5.3
Total Long-Term Liabilities	11.93	12.04	18.72	15.9	25.71	23.83
Total Liabilities	15.29	18.04	34.34	38.38	58.57	35.05
Common Stock	1,448	1,421	1,410	1,350	1,319	1,287
Additional Paid-in Capital	74.32	83.32	82.05	81.27	72.41	65.49
Accumulated Other Comprehensive Income	-48.24	-48.1	-48.14	-48.42	-50.49	-48.34
Retained Earnings	-1,216	-1,380	-1,347	-1,277	-1,204	-1,134
Shareholders' Equity	258.73	76.58	97.37	106.02	136.85	169.44
Total Liabilities & Equity	274.03	94.62	131.71	144.4	195.42	204.49
Total Debt	3.63	4.19	6.12	8.72	12.55	18.91
Net Cash (Debt)	89	87.28	116.51	117.28	134.36	136.41
Net Cash Growth	-4.39%	-25.08%	-0.66%	-12.71%	-1.50%	35.42%
Net Cash Per Share	0.46	0.46	0.63	0.71	0.89	1.28
Book Value	258.73	76.58	97.37	106.02	136.85	169.44
Book Value Per Share	1.33	0.40	0.52	0.64	0.91	1.59
Tangible Book Value	258.73	76.58	97.37	106.02	136.85	169.44
Tangible Book Value Per Share	1.33	0.40	0.52	0.64	0.91	1.59

SEC Filings: 10-K · 10-Q